MedPath

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

Phase 3
Completed
Conditions
Brain and Central Nervous System Tumors
Interventions
Radiation: radiation therapy
Registration Number
NCT00182819
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known whether radiation therapy is more effective than temozolomide in treating gliomas.

PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared to temozolomide in treating patients with gliomas.

Detailed Description

OBJECTIVES:

Primary

* Compare the progression-free survival of patients with low-grade gliomas treated with radiotherapy vs temozolomide.

Secondary

* Compare the overall survival of patients treated with these regimens.

* Determine whether the incidence of late toxicity can be decreased in patients who are randomized to receive temozolomide.

* Compare the toxic effects of these regimens in these patients.

* Compare the quality of life of patients treated with these regimens.

OUTLINE: This is a randomized, controlled, multicenter study. Patients are stratified according to participating center, chromosome 1p status (deleted vs normal vs undeterminable), contrast enhancement on MRI (yes vs no), age (\< 40 years vs ≥ 40 years), and WHO performance status (0 or 1 vs 2). Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients undergo radiotherapy once daily, 5 days a week, for a total of 28 fractions (i.e., 5½ weeks).

* Arm II: Patients receive oral temozolomide once daily on days 1-21. Treatment repeats every 28 days for up to 12 courses in the absence of disease progression or unacceptable toxicity.

Quality of life is assessed at baseline and then every 3 months until disease progression.

After completion of study treatment, patients are followed every 6 months for survival.

Peer Reviewed and Funded or Endorsed by Cancer Research UK

PROJECTED ACCRUAL: A minimum of 699 patients (a total of 466 randomized \[233 per treatment arm\]) will be accrued for this study within 5 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
709
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
radiotherapyradiation therapyRadiotherapy (control arm), 50.4 Gy, standard fractionation (28 x 1.8 Gy), conformal techniques
TemozolomidetemozolomideTemozolomide 75 mg/m2 daily x 21 days, q 28 days until progression or for max. 12 cycles (experimental arm)
Primary Outcome Measures
NameTimeMethod
Progression-free survival5 years
Secondary Outcome Measures
NameTimeMethod
Overall survival5 years
Adverse events as measured by CTCAE v3.0As indicated in the protocol
Quality of life as measured by QLQ-C30 v3.0 and EORTC BN-20every 3 months until progression, and then every 6 months until death
Mini-Mental State Examinationevery 3 months until progression, and then every 6 months until death

Trial Locations

Locations (89)

Edmond Odette Cancer Centre at Sunnybrook

🇨🇦

Toronto, Ontario, Canada

Princess Margaret Hospital

🇨🇦

Toronto, Ontario, Canada

Allan Blair Cancer Centre at Pasqua Hospital

🇨🇦

Regina, Saskatchewan, Canada

University College Hospital

🇬🇧

London, England, United Kingdom

Royal Marsden - London

🇬🇧

London, England, United Kingdom

Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere

🇫🇷

Paris, France

CHU de la Timone

🇫🇷

Marseille, France

Centre Regional Rene Gauducheau

🇫🇷

Nantes-Saint Herblain, France

Institut Claudius Regaud

🇫🇷

Toulouse, France

Centre Eugene Marquis

🇫🇷

Rennes, France

Centre Paul Strauss

🇫🇷

Strasbourg, France

Gustave Roussy

🇫🇷

Villejuif, France

Peter MacCallum Cancer Centre

🇦🇺

East Melbourne, Victoria, Australia

Austin and Repatriation Medical Centre

🇦🇺

Heidelberg West, Victoria, Australia

Liverpool Hospital

🇦🇺

Liverpool, Australia

Prince of Wales Private Hospital

🇦🇺

Randwick, New South Wales, Australia

Calvary Mater Newcastle

🇦🇺

Waratah, New South Wales, Australia

Sydney Cancer Centre at Royal Prince Alfred Hospital

🇦🇺

Sydney, New South Wales, Australia

Royal Brisbane and Women's Hospital

🇦🇺

Brisbane, Queensland, Australia

Mater Adult Hospital

🇦🇺

South Brisbane, Queensland, Australia

Sir Charles Gairdner Hospital - Nedlands

🇦🇺

Nedlands, Western Australia, Australia

Medical University Vienna - General Hospital AKH

🇦🇹

Vienna, Austria

Hopital Universitaire Erasme

🇧🇪

Brussels, Belgium

Universitair Ziekenhuis Brussel

🇧🇪

Brussels, Belgium

U.Z. Leuven - Campus Gasthuisberg

🇧🇪

Leuven, Belgium

Margaret and Charles Juravinski Cancer Centre

🇨🇦

Hamilton, Ontario, Canada

Tom Baker Cancer Centre - Calgary

🇨🇦

Calgary, Alberta, Canada

London Regional Cancer Program at London Health Sciences Centre

🇨🇦

London, Ontario, Canada

Hopital Notre-Dame du CHUM

🇨🇦

Montreal, Quebec, Canada

University Hospital of Linkoping

🇸🇪

Linkoping, Sweden

Lancashire Teaching Hospitals NHS Foundation Trust - Royal Preston Hospital

🇬🇧

Preston, United Kingdom

Universitaetsklinikum Tuebingen

🇩🇪

Tuebingen, Germany

Universitaetskliniken Regensburg

🇩🇪

Regensburg, Germany

Gloucestershire Hospital NHS Foundation Trust - Cheltenham General Hospital

🇬🇧

Cheltenham, United Kingdom

Umea Universitet

🇸🇪

Umea, Sweden

National Cancer Institute of Egypt

🇪🇬

Cairo, Egypt

CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre

🇫🇷

Bordeaux, France

Institut Bergonie

🇫🇷

Bordeaux, France

CHU de Grenoble - Hopital de la Tronche

🇫🇷

Grenoble, France

Uppsala University Hospital

🇸🇪

Uppsala, Sweden

Addenbrooke's Hospital

🇬🇧

Cambridge, England, United Kingdom

Western General Hospital

🇬🇧

Edinburgh, United Kingdom

Oxford University Hospitals NHS Trust - Churchill Hospital

🇬🇧

Oxford, United Kingdom

Vrije Universiteit Medisch Centrum

🇳🇱

Amsterdam, Netherlands

University Medical Center Groningen

🇳🇱

Groningen, Netherlands

Hospital General Vall D'Hebron

🇪🇸

Barcelona, Spain

Erasmus MC Cancer Institute - location Daniel den Hoed

🇳🇱

Rotterdam, Netherlands

Ospedale San Raffaele

🇮🇹

Milano, Italy

Christie Hospital

🇬🇧

Manchester, England, United Kingdom

Centre Hospitalier Universitaire Vaudois - Lausanne

🇨🇭

Lausanne, Switzerland

University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre

🇬🇧

Bristol, Avon, United Kingdom

Royal Marsden - Surrey

🇬🇧

Sutton, England, United Kingdom

UniversitaetsSpital Zurich

🇨🇭

Zurich, Switzerland

Hospital Clinic de Barcelona

🇪🇸

Barcelona, Spain

Medisch Centrum Haaglanden - Westeinde

🇳🇱

Den Haag, Netherlands

Maastro Clinic - Maastricht Radiation Oncology

🇳🇱

Maastricht, Netherlands

Radboud University Medical Center Nijmegen

🇳🇱

Nijmegen, Netherlands

Dr. Bernard Verbeeten Instituut

🇳🇱

Tilburg, Netherlands

Skane University Hospital

🇸🇪

Lund, Sweden

ICO Girona - Hospital Doctor Josep Trueta (Institut Catala D'Oncologia)

🇪🇸

Girona, Spain

ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia)

🇪🇸

L'Hospitalet de Llobregat, Spain

National University of Singapore

🇸🇬

Singapore, Singapore

Royal Free Hospital

🇬🇧

London, United Kingdom

ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia)

🇪🇸

Badalona - (Barcelona), Spain

Leeds Cancer Centre at St. James's University Hospital

🇬🇧

Leeds, England, United Kingdom

Canterbury Health Laboratories

🇳🇿

Christchurch, New Zealand

James Cook University Hospital

🇬🇧

Middlesbrough, England, United Kingdom

Hospital Clinico Universitario de Barcelona

🇪🇸

Barcelona, Spain

Centre Francois Baclesse

🇱🇺

Esch / Alzette, Luxembourg

Royal North Shore Hospital

🇦🇺

St. Leonards, New South Wales, Australia

Princess Alexandra Hospital

🇦🇺

Brisbane, Queensland, Australia

Universitatsklinikum Heidelberg

🇩🇪

Heidelberg, Germany

BC Cancer Agency

🇨🇦

Vancouver, Canada

Mcgill University Health Centre - Gerald Bronfman Centre - Dept Of Oncology

🇨🇦

Montreal, Quebec, Canada

Universitaetsklinikum Leipzig

🇩🇪

Leipzig, Germany

National Institute Of Neurosurgery

🇭🇺

Budapest, Hungary

Ospedale Bellaria

🇮🇹

Bologna, Italy

Rambam Health Care Campus, Oncology Institute

🇮🇱

Haifa, Israel

Istituto Regina Elena / Istituti Fisioterapici Ospitalieri

🇮🇹

Roma, Italy

Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino

🇮🇹

Turin, Italy

Academisch Medisch Centrum - Universiteit van Amsterdam

🇳🇱

Amsterdam, Netherlands

Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA

🇵🇹

Lisbon, Portugal

Oncology Institute of Southern Switzerland - Ospedale Regionale Bellinzona e Valli

🇨🇭

Bellinzona, Switzerland

Clatterbridge Centre for Oncology

🇬🇧

Bebington, Wirral, England, United Kingdom

Alfred Hospital

🇦🇺

Prahran, Victoria, Australia

CancerCare Manitoba

🇨🇦

Winnipeg, Manitoba, Canada

Nova Scotia Cancer Centre

🇨🇦

Halifax, Nova Scotia, Canada

Saint John Regional Hospital

🇨🇦

Saint John, New Brunswick, Canada

Cancer Research Centre at Weston Park Hospital

🇬🇧

Sheffield, England, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath